Taiwan · Delayed Price · Currency is TWD Jia Jie Biomedical Statistics
Total Valuation
TPEX:4109 has a market cap or net worth of TWD 1.63 billion. The enterprise value is 1.15 billion.
| Market Cap | 1.63B |
| Enterprise Value | 1.15B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Sep 24, 2025 |
Share Statistics
TPEX:4109 has 118.74 million shares outstanding. The number of shares has increased by 16.11% in one year.
| Current Share Class | 118.74M |
| Shares Outstanding | 118.74M |
| Shares Change (YoY) | +16.11% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | n/a |
| Float | 94.45M |
Valuation Ratios
The trailing PE ratio is 499.75.
| PE Ratio | 499.75 |
| Forward PE | n/a |
| PS Ratio | 3.37 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 52.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.87, with an EV/FCF ratio of -26.58.
| EV / Earnings | 353.00 |
| EV / Sales | 2.38 |
| EV / EBITDA | 29.87 |
| EV / EBIT | 53.72 |
| EV / FCF | -26.58 |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.93 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | -0.20 |
| Interest Coverage | 105.88 |
Financial Efficiency
Return on equity (ROE) is 0.42% and return on invested capital (ROIC) is 0.54%.
| Return on Equity (ROE) | 0.42% |
| Return on Assets (ROA) | 0.80% |
| Return on Invested Capital (ROIC) | 0.54% |
| Return on Capital Employed (ROCE) | 1.27% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.29 |
| Inventory Turnover | 12.41 |
Taxes
In the past 12 months, TPEX:4109 has paid 15.84 million in taxes.
| Income Tax | 15.84M |
| Effective Tax Rate | 71.23% |
Stock Price Statistics
The stock price has decreased by -40.82% in the last 52 weeks. The beta is -0.00, so TPEX:4109's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -40.82% |
| 50-Day Moving Average | 14.83 |
| 200-Day Moving Average | 15.93 |
| Relative Strength Index (RSI) | 27.79 |
| Average Volume (20 Days) | 259,379 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4109 had revenue of TWD 482.03 million and earned 3.26 million in profits. Earnings per share was 0.03.
| Revenue | 482.03M |
| Gross Profit | 159.97M |
| Operating Income | 21.39M |
| Pretax Income | 22.24M |
| Net Income | 3.26M |
| EBITDA | 35.81M |
| EBIT | 21.39M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 515.25 million in cash and 8.46 million in debt, with a net cash position of 506.80 million or 4.27 per share.
| Cash & Cash Equivalents | 515.25M |
| Total Debt | 8.46M |
| Net Cash | 506.80M |
| Net Cash Per Share | 4.27 |
| Equity (Book Value) | 1.68B |
| Book Value Per Share | 13.91 |
| Working Capital | 442.44M |
Cash Flow
In the last 12 months, operating cash flow was 30.75 million and capital expenditures -73.97 million, giving a free cash flow of -43.23 million.
| Operating Cash Flow | 30.75M |
| Capital Expenditures | -73.97M |
| Free Cash Flow | -43.23M |
| FCF Per Share | -0.36 |
Margins
Gross margin is 33.19%, with operating and profit margins of 4.44% and 0.68%.
| Gross Margin | 33.19% |
| Operating Margin | 4.44% |
| Pretax Margin | 4.61% |
| Profit Margin | 0.68% |
| EBITDA Margin | 7.43% |
| EBIT Margin | 4.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 3.65%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 3.65% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.11% |
| Shareholder Yield | -12.46% |
| Earnings Yield | 0.20% |
| FCF Yield | -2.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2019. It was a reverse split with a ratio of 0.8487883546.
| Last Split Date | Mar 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.8487883546 |
Scores
TPEX:4109 has an Altman Z-Score of 8.81 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.81 |
| Piotroski F-Score | 6 |